Optimization of AID somatic hypermutations system and in situ class switching of Globo H antibodies
博士 === 國立陽明大學 === 生化暨分子生物研究所 === 106 === Monoclonal antibodies have become a mainstream treatment option in oncology. Most therapeutic targets have been limited to surface receptors overexpressed on cancer cells. Globo H (GH) is a newly appreciated glycolipid for cancer targeting, which is overexpre...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/2c257z |